Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313322406> ?p ?o ?g. }
- W4313322406 endingPage "3253" @default.
- W4313322406 startingPage "3240" @default.
- W4313322406 abstract "Selective internal radiotherapy is widely used for liver dominant diseases of solid tumors. However, data about sequential treatment and prognostic factors are lacking.We consecutively included all 209 patients who received a selective internal radiotherapy intervention between January 2015 and May 2019. A retrospective analysis of their electronic patient records was performed regarding diagnosis of cancer, previous therapies and applied radioactive activity. A multicenter follow-up at least 6 weeks after intervention to assess radiological response and irregular subsequent follow-ups to asses disease progression were conducted. In addition, subgroup analyses were carried out.The most frequently treated indications were hepatocellular carcinoma (37%), colorectal cancers (14%), neuroendocrine tumors (9%), and breast cancer (8%). In hepatocellular carcinoma, selective internal radiotherapy was most performed without prior systemic therapy (40%), and for the remaining indications, most often after surgery with systemic therapy in sequence. Local radiological response, defined as either regression or stable disease, was assessed at least 6 weeks after intervention and showed 52% across all indications. Hepatocellular carcinoma (59%) and breast cancer (67%) showed an excellent, colorectal cancers (29%) a particularly poor response rate. Neuroendocrine tumors showed the third longest median post-selective internal radiation therapy (SIRT) survival with 12.4 months and the second longest median progression-free time with 5.2 months. Hepatocellular carcinoma showed even better results with a post-SIRT survival of 15.7 months and a median progression-free time of 5.3 months. Pancreatic neuroendocrine tumors showed significantly worse outcomes than other neuroendocrine tumors, regarding median post-SIRT survival and median progression-free time. No relevant SIRT related differences among sexes were detected.Patients with neuroendocrine tumors, breast cancer in late therapy lines and early-stage hepatocellular carcinoma seem to show better responses to SIRT than other entities. Colorectal cancers were mainly treated with SIRT in a second or third therapy line but with considerably weaker results than other entities." @default.
- W4313322406 created "2023-01-06" @default.
- W4313322406 creator A5008642365 @default.
- W4313322406 creator A5025058942 @default.
- W4313322406 creator A5026314550 @default.
- W4313322406 creator A5036774533 @default.
- W4313322406 creator A5043689487 @default.
- W4313322406 creator A5073505986 @default.
- W4313322406 creator A5073563210 @default.
- W4313322406 date "2022-12-01" @default.
- W4313322406 modified "2023-09-25" @default.
- W4313322406 title "A descriptive analysis of the characteristics, treatment response and prognosis of hepatic dominant solid tumors undergoing selective internal radiation therapy (SIRT)" @default.
- W4313322406 cites W187570847 @default.
- W4313322406 cites W1972656626 @default.
- W4313322406 cites W1981536905 @default.
- W4313322406 cites W1984851072 @default.
- W4313322406 cites W2024066637 @default.
- W4313322406 cites W2062785452 @default.
- W4313322406 cites W2066593706 @default.
- W4313322406 cites W2072784690 @default.
- W4313322406 cites W2103789431 @default.
- W4313322406 cites W2115143871 @default.
- W4313322406 cites W2130629599 @default.
- W4313322406 cites W2135551822 @default.
- W4313322406 cites W2137042709 @default.
- W4313322406 cites W2138081106 @default.
- W4313322406 cites W2141444851 @default.
- W4313322406 cites W2142249368 @default.
- W4313322406 cites W2163351155 @default.
- W4313322406 cites W2166305638 @default.
- W4313322406 cites W2167503521 @default.
- W4313322406 cites W2235074195 @default.
- W4313322406 cites W2294798900 @default.
- W4313322406 cites W2296193683 @default.
- W4313322406 cites W2337532163 @default.
- W4313322406 cites W2401997264 @default.
- W4313322406 cites W2469358888 @default.
- W4313322406 cites W2508639256 @default.
- W4313322406 cites W2509930573 @default.
- W4313322406 cites W2511286678 @default.
- W4313322406 cites W2587863280 @default.
- W4313322406 cites W2588675203 @default.
- W4313322406 cites W2592093096 @default.
- W4313322406 cites W2744084279 @default.
- W4313322406 cites W2754961196 @default.
- W4313322406 cites W2783686102 @default.
- W4313322406 cites W2893919806 @default.
- W4313322406 cites W2898512683 @default.
- W4313322406 cites W2898523929 @default.
- W4313322406 cites W2900478373 @default.
- W4313322406 cites W2901728462 @default.
- W4313322406 cites W2913559246 @default.
- W4313322406 cites W2991301258 @default.
- W4313322406 cites W3015390571 @default.
- W4313322406 cites W3035865887 @default.
- W4313322406 cites W3133992342 @default.
- W4313322406 cites W3137696361 @default.
- W4313322406 cites W3182383157 @default.
- W4313322406 cites W4210992155 @default.
- W4313322406 cites W4213293146 @default.
- W4313322406 cites W4242769447 @default.
- W4313322406 cites W4245784696 @default.
- W4313322406 cites W4285719527 @default.
- W4313322406 doi "https://doi.org/10.21037/jgo-22-122" @default.
- W4313322406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36636090" @default.
- W4313322406 hasPublicationYear "2022" @default.
- W4313322406 type Work @default.
- W4313322406 citedByCount "0" @default.
- W4313322406 crossrefType "journal-article" @default.
- W4313322406 hasAuthorship W4313322406A5008642365 @default.
- W4313322406 hasAuthorship W4313322406A5025058942 @default.
- W4313322406 hasAuthorship W4313322406A5026314550 @default.
- W4313322406 hasAuthorship W4313322406A5036774533 @default.
- W4313322406 hasAuthorship W4313322406A5043689487 @default.
- W4313322406 hasAuthorship W4313322406A5073505986 @default.
- W4313322406 hasAuthorship W4313322406A5073563210 @default.
- W4313322406 hasBestOaLocation W43133224061 @default.
- W4313322406 hasConcept C121608353 @default.
- W4313322406 hasConcept C126322002 @default.
- W4313322406 hasConcept C143998085 @default.
- W4313322406 hasConcept C2776694085 @default.
- W4313322406 hasConcept C2778019345 @default.
- W4313322406 hasConcept C2778822529 @default.
- W4313322406 hasConcept C2779185275 @default.
- W4313322406 hasConcept C2779984678 @default.
- W4313322406 hasConcept C509974204 @default.
- W4313322406 hasConcept C526805850 @default.
- W4313322406 hasConcept C71924100 @default.
- W4313322406 hasConcept C90924648 @default.
- W4313322406 hasConceptScore W4313322406C121608353 @default.
- W4313322406 hasConceptScore W4313322406C126322002 @default.
- W4313322406 hasConceptScore W4313322406C143998085 @default.
- W4313322406 hasConceptScore W4313322406C2776694085 @default.
- W4313322406 hasConceptScore W4313322406C2778019345 @default.
- W4313322406 hasConceptScore W4313322406C2778822529 @default.
- W4313322406 hasConceptScore W4313322406C2779185275 @default.
- W4313322406 hasConceptScore W4313322406C2779984678 @default.
- W4313322406 hasConceptScore W4313322406C509974204 @default.